eClinical Tech News

Candel Therapeutics announced promising Phase 1b clinical trial results for CAN-2409 combined with nivolumab and standard care in newly...

Medera Inc. announced updated positive results from its Phase 1/2a clinical trial of SRD-002, a gene therapy for heart...

Connect Biopharma announced positive Phase 2 trial results for rademikibart, a potential new biologic treatment for moderate-to-severe uncontrolled asthma....

BridgeBio Pharma presented data from a subgroup analysis of its Phase 3 ATTRibute-CM trial, demonstrating acoramidis significantly improved clinical...

Tenaya Therapeutics announced interim Phase 1b/2 clinical trial data for TN-201, a gene therapy for •MYBPC3•-associated hypertrophic cardiomyopathy (HCM)....

NeOnc Technologies Holdings, Inc. has received Rare Pediatric Disease Designation (RPDD) from the FDA for its perillyl alcohol (NEO100™)...

Silexion Therapeutics Corp. (NASDAQ: SLXN) is expanding the development plan for its next-generation siRNA candidate, SIL204, to treat KRAS-driven...

Corbus Pharmaceuticals has dosed the first subject in a Phase 1 trial for CRB-913, an investigational drug for obesity....

FibroGen announced positive results from a Phase 1 study of FG-3246, an antibody-drug conjugate targeting CD46, in patients with...

Anthos Therapeutics presented new analyses from the AZALEA-TIMI 71 study at the American College of Cardiology Annual Scientific Session....